NPs Basic Information
|
Name |
LL-Z1271beta
|
| Molecular Formula | C16H24O5 | |
| IUPAC Name* |
(1S,4aR,5R,7S,8aR)-5-(carboxymethyl)-7-hydroxy-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
|
|
| SMILES |
C[C@]12CCC[C@]([C@@H]1C[C@@H](C(=C)[C@@H]2CC(=O)O)O)(C)C(=O)O
|
|
| InChI |
InChI=1S/C16H24O5/c1-9-10(7-13(18)19)15(2)5-4-6-16(3,14(20)21)12(15)8-11(9)17/h10-12,17H,1,4-8H2,2-3H3,(H,18,19)(H,20,21)/t10-,11-,12+,15+,16-/m0/s1
|
|
| InChIKey |
ZVBBGMJUCZRFPO-KSMPYDNASA-N
|
|
| Synonyms |
LL-Z1271beta; CHEMBL2011788; 32179-19-4
|
|
| CAS | NA | |
| PubChem CID | 70691548 | |
| ChEMBL ID | CHEMBL2011788 |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 296.36 | ALogp: | 1.5 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 94.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 21 | QED Weighted: | 0.696 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.98 | MDCK Permeability: | 0.00004820 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.088 |
| Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.025 |
| 30% Bioavailability (F30%): | 0.007 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.153 | Plasma Protein Binding (PPB): | 52.29% |
| Volume Distribution (VD): | 0.211 | Fu: | 50.27% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.161 |
| CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.063 |
| CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.455 |
| CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.113 |
| CYP3A4-inhibitor: | 0.033 | CYP3A4-substrate: | 0.036 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 1.874 | Half-life (T1/2): | 0.837 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.298 |
| Drug-inuced Liver Injury (DILI): | 0.112 | AMES Toxicity: | 0.005 |
| Rat Oral Acute Toxicity: | 0.94 | Maximum Recommended Daily Dose: | 0.97 |
| Skin Sensitization: | 0.375 | Carcinogencity: | 0.473 |
| Eye Corrosion: | 0.785 | Eye Irritation: | 0.844 |
| Respiratory Toxicity: | 0.959 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005547 |  |
1.000 | D01CKY |  |
0.305 | ||
| ENC003143 |  |
0.688 | D04VIS |  |
0.295 | ||
| ENC001844 |  |
0.506 | D00HWO |  |
0.272 | ||
| ENC005922 |  |
0.493 | D0S0NK |  |
0.263 | ||
| ENC001071 |  |
0.452 | D0G3SH |  |
0.257 | ||
| ENC003162 |  |
0.418 | D03ZTE |  |
0.257 | ||
| ENC001350 |  |
0.408 | D0KR5B |  |
0.248 | ||
| ENC002603 |  |
0.400 | D0M4WA |  |
0.245 | ||
| ENC005749 |  |
0.386 | D0V9DZ |  |
0.243 | ||
| ENC002438 |  |
0.375 | D08PIQ |  |
0.243 | ||